Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: subgroup analyses of a randomized clinical trial
Authors
Ilson, DHTabernero, J
Prokharau, A
Arkenau, HT
Ghidini, M
Fujitani, K
Van, CE
Thuss-Patience, P
Beretta, GD
Mansoor, Was
Zhavrid, E
Alsina, M
George, B
Catenacci, D
McGuigan, S
Makris, L
Doi, T
Shitara, K
Affiliation
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New YorkIssue Date
2019
Metadata
Show full item recordCitation
Ilson DH, Tabernero J, Prokharau A, Arkenau HT, Ghidini M, Fujitani K, et al. Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: subgroup analyses of a randomized clinical trial. JAMA Oncol. 2019.Journal
JAMA OncologyDOI
10.1001/jamaoncol.2019.3531PubMed ID
31600365Additional Links
https://dx.doi.org/10.1001/jamaoncol.2019.3531Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1001/jamaoncol.2019.3531
Scopus Count
Collections
Related articles
- Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).
- Authors: Shitara K, Doi T, Hosaka H, Thuss-Patience P, Santoro A, Longo F, Ozyilkan O, Cicin I, Park D, Zaanan A, Pericay C, Özgüroğlu M, Alsina M, Makris L, Benhadji KA, Ilson DH
- Issue date: 2022 May
- Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
- Authors: Mansoor W, Arkenau HT, Alsina M, Shitara K, Thuss-Patience P, Cuffe S, Dvorkin M, Park D, Ando T, Van Den Eynde M, Beretta GD, Zaniboni A, Doi T, Tabernero J, Ilson DH, Makris L, Benhadji KA, Van Cutsem E
- Issue date: 2021 Jul
- Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
- Authors: Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalçın Ş, Fujitani K, Beretta GD, Cutsem EV, Winkler RE, Makris L, Ilson DH, Tabernero J
- Issue date: 2018 Nov
- Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study.
- Authors: Tabernero J, Shitara K, Zaanan A, Doi T, Lorenzen S, Van Cutsem E, Fornaro L, Catenacci DVT, Fougeray R, Moreno SR, Azcue P, Arkenau HT, Alsina M, Ilson DH
- Issue date: 2021 Aug
- A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.
- Authors: Saif MW, Becerra CR, Fakih MG, Sun W, Popovic L, Krishnamurthi S, George TJ, Rudek MA, Shepard DR, Skopek J, Sramek V, Zaric B, Yamamiya I, Benhadji KA, Hamada K, He Y, Rosen L
- Issue date: 2021 Sep